Low-Dose radiation therapy for benign pathologies

Radiotherapy (RT) has always been a mainstay for malignant tumors therapy, but it is also used for benign pathology. The application of low or intermediate doses of RT has been widely studied. This topic was presented and discussed in the last XX GOCO (Grup Oncològic Català-Occità) meeting. The aim...

Full description

Saved in:
Bibliographic Details
Published inReports of practical oncology and radiotherapy Vol. 25; no. 2; pp. 250 - 254
Main Authors Torres Royo, Laura, Antelo Redondo, Gabriela, Árquez Pianetta, Miguel, Arenas Prat, Meritxell
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.03.2020
Elsevier
Subjects
Anti-Inflammatory
Anti-Proliferation
Benign
Low dose radiation
Non-Malignant
Original research article
Radio-Induced cancer risk
Anti-Inflammatory
Anti-Proliferation
Non-Malignant
Low dose radiation
Radio-Induced cancer risk
Benign
Online AccessGet full text

Cover

More Information
Summary:Radiotherapy (RT) has always been a mainstay for malignant tumors therapy, but it is also used for benign pathology. The application of low or intermediate doses of RT has been widely studied. This topic was presented and discussed in the last XX GOCO (Grup Oncològic Català-Occità) meeting. The aim of this article is to review the indications of low dose irradiation (LD-RT), total dose and different fractionations, the public to whom it can be directed, and to offer an analysis about secondary effects. We believe it can be useful not only for radiation oncologists, but for other physicians to consider this option for future patients.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1507-1367
2083-4640
DOI:10.1016/j.rpor.2020.02.004